Literature DB >> 12163338

Is cannabinoid transmission involved in rewarding properties of drugs of abuse?

Daniela Parolaro1, Tiziana Rubino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12163338      PMCID： PMC1573453          DOI： 10.1038/sj.bjp.0704826

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  9 in total

1.  CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats.

Authors:  L Fattore; M C Martellotta; G Cossu; M S Mascia; W Fratta
Journal:  Behav Brain Res       Date:  1999-10       Impact factor: 3.332

2.  Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse.

Authors:  G Cossu; C Ledent; L Fattore; A Imperato; G A Böhme; M Parmentier; W Fratta
Journal:  Behav Brain Res       Date:  2001-01-08       Impact factor: 3.332

3.  Functional interaction between opioid and cannabinoid receptors in drug self-administration.

Authors:  M Navarro; M R Carrera; W Fratta; O Valverde; G Cossu; L Fattore; J A Chowen; R Gomez; I del Arco; M A Villanua; R Maldonado; G F Koob; F Rodriguez de Fonseca
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

4.  Role of the endocannabinoid system in MDMA intracerebral self-administration in rats.

Authors:  Daniela Braida; Mariaelvina Sala
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

5.  Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.

Authors:  Emmanuel Valjent; Jennifer M Mitchell; Marie-Jo Besson; Jocelyne Caboche; Rafael Maldonado
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

6.  Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716.

Authors:  G Colombo; R Agabio; M Fà; L Guano; C Lobina; A Loche; R Reali; G L Gessa
Journal:  Alcohol Alcohol       Date:  1998 Mar-Apr       Impact factor: 2.826

7.  Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.

Authors:  V Di Marzo; F Berrendero; T Bisogno; S González; P Cavaliere; J Romero; M Cebeira; J A Ramos; J J Fernández-Ruiz
Journal:  J Neurochem       Date:  2000-04       Impact factor: 5.372

8.  Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.

Authors:  G Tanda; F E Pontieri; G Di Chiara
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

9.  Dopamine activation of endogenous cannabinoid signaling in dorsal striatum.

Authors:  A Giuffrida; L H Parsons; T M Kerr; F Rodríguez de Fonseca; M Navarro; D Piomelli
Journal:  Nat Neurosci       Date:  1999-04       Impact factor: 24.884
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.